Search

We reviewed the available scientific evidence to determine if health navigation improves patient outcomes for people with HIV.

Ribavirin is a type of antiviral medication. It is approved in Canada for the treatment of chronic hepatitis C when used in combination with direct-acting antiviral medications.

This article outlines hepatitis C transmission routes and the factors that contribute to the transmission risk for each.

Testing is the first and most crucial step in the HIV treatment cascade. Rapid point-of-care (POC) HIV testing allows people to test and learn their HIV status during the same visit. A review of the…

This article explores the impact of viral hepatitis on immigrants and newcomers in Canada, including the barriers that people face in accessing prevention, testing and treatment services.

An overview of Canadian HIV, hepatitis C and STBBI prevention resources on gay, bisexual and other men who have sex with men and for service providers who support them.

Easy-to-read and illustrated information for gay men living with HIV, giving basic information on how hepatitis C is passed on during sex.

In a recent study, specialized healthcare providers in British Columbia offered valuable insights into their strategies for engaging and re-engaging people living with HIV in healthcare.

Researchers examined chronic health conditions in over 28,000 people with HIV over a decade. Over time, people on HIV treatment had a decreasing chance of one or two hospitalizations. Those who were…

This article explores how dangerous changes in the illegal drug supply came about, why the unpredictable strength and contents of illegal drugs makes them so dangerous and implications for service…

This booklet provides information on seven of the most effective ways to prevent HIV: PrEP, PEP, HIV treatment, condoms, types of sex with a lower risk of HIV transmission, using new drug use…